International Isotopes Amends Acquisition of AMICI, Expanding Product Line

International Isotopes Inc. Amends Acquisition of AMICI

On January 9, 2025, International Isotopes Inc. (OTCQB: INIS), headquartered in Idaho Falls, announced significant updates regarding its acquisition of AMICI, Inc. This amendment to the original Asset Purchase Agreement, established on June 16, 2023, aims to address previous inventory and asset shortfalls. Under the new terms, International Isotopes will acquire crucial components including manufacturing molds, device registrations, trademarks, and production rights associated with the AMICI line of Xenon System products. This acquisition also encompasses registered intellectual property related to the innovative Swirler® and Tru-Fit™ mouthpieces.

Shahe Bagerdjian, President of INIS, expressed satisfaction with finalizing the agreement, highlighting the significance of having full control over the intellectual property linked to the Swirler® and Tru-Fit™ lines. "We look forward to integrating the Xenon System into our RadVent medical device lineup in 2025," he stated. This incorporation promises to enhance the company's existing portfolio and competitive edge in the medical device market.

AMICI, Inc. has been recognized as a leading manufacturer and distributor in the field of diagnostic and therapeutic products specifically designed for lung ventilation. Its offerings include a range of products such as masks, mouthpieces, bacteria and virus filters, absorbents, and the groundbreaking Swirler® Radioaerosol System. This new acquisition is expected to bolster International Isotopes' medical device segment significantly, with plans to market under the established RadVent product line.

About International Isotopes Inc.

Founded in 1995, International Isotopes Inc. specializes in the production of radioisotope-focused products. The company manufactures and supplies generic sodium iodide I-131 radio-pharmaceuticals for treating hyperthyroidism and thyroid cancer. Additionally, it offers a complete line of calibration and reference standards aimed at nuclear pharmacies as well as SPECT/PET imaging systems through its RadQual brand. Their operations extend to manufacturing Cobalt-60 sealed source products and providing contract manufacturing services for various drug products while also catering to third-party clients involved in theranostics.

In a strategic move to enhance its international footprint, International Isotopes has recently launched a joint venture in China with Alpha Nuclides, known as Radnostix China. This partnership is set to introduce the company's innovative products to a broader market. Furthermore, in 2025, they plan to unveil the RadVent brand of medical devices, which will include the much-anticipated Swirler® and Tru-Fit™ product lines, expanding their operational scope and enhancing patient care in the medical field.

For further information about the RadVent Swirler®, Tru-Fit™, and Xenon Systems, interested parties are encouraged to visit radvent.com.